Radiation Therapy Alone in cT1-3N0 Non-small Cell Lung Cancer Patients Who Are Unfit for Surgical Resection or Stereotactic Radiation Therapy: Comparison of Risk-Adaptive Dose Schedulesopen access
- Authors
- Cho, WK[Cho, Won Kyung]; Noh, JM[Noh, Jae Myoung]; Ahn, YC[Ahn, Yong Chan]; Oh, D[Oh, Dongryul]; Pyo, H[Pyo, Hongryull]
- Issue Date
- Oct-2016
- Publisher
- KOREAN CANCER ASSOCIATION
- Keywords
- Non-small cell lung carcinoma; Radiotherapy; Dose fractionation
- Citation
- CANCER RESEARCH AND TREATMENT, v.48, no.4, pp.1187 - 1195
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- CANCER RESEARCH AND TREATMENT
- Volume
- 48
- Number
- 4
- Start Page
- 1187
- End Page
- 1195
- URI
- https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/35031
- DOI
- 10.4143/crt.2015.391
- ISSN
- 1598-2998
- Abstract
- Purpose High dose definitive radiation therapy (RT) alone is recommended to patients with cT1-3N0 non-small cell lung cancer, who are unfit for surgery or stereotactic RT. This study was conducted to evaluate the clinical outcomes and cost-effectiveness following RT alone using two different modest hypofractionation dose schemes. Materials and Methods Between 2001 and 2014, 124 patients underwent RT alone. From 2001 till 2010, 60 Gy in 20 fractions was delivered to 79 patients (group 1). Since 2011, 60 Gy in 20 fractions (group 2, 20 patients), and 60 Gy in 15 fractions (group 3, 25 patients) were selectively chosen depending on estimated risk of esophagitis. Results At follow-up of 16.7 months, 2-year rates of local control, progression free survival, and overall survival were 62.6%, 39.1%, and 59.1%, respectively. Overall survival was significantly better in group 3 (p=0.002). In multivariate analyses, cT3 was the most powerful adverse factor affecting clinical outcomes. Incidence and severity of radiation pneumonitis were not different among groups, while no patients developed grade 2 esophagitis in group 3 (p=0.003). Under current Korean Health Insurance Policy, RT cost per person was 22.5% less in group 3 compared with others. Conclusion The current study demonstrated that 60 Gy in 15 fractions instead of 60 Gy in 20 fractions resulted in comparable clinical outcomes with excellent safety, direct cost saving, and improved convenience to the patients with tumors located at >= 1.5 cm from the esophagus.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.